IDYA
Price
$22.10
Change
+$0.18 (+0.82%)
Updated
Jul 3 closing price
Capitalization
1.92B
39 days until earnings call
JANX
Price
$24.45
Change
+$0.39 (+1.62%)
Updated
Jul 3 closing price
Capitalization
1.42B
39 days until earnings call
Interact to see
Advertisement

IDYA vs JANX

Header iconIDYA vs JANX Comparison
Open Charts IDYA vs JANXBanner chart's image
IDEAYA Biosciences
Price$22.10
Change+$0.18 (+0.82%)
Volume$522.89K
Capitalization1.92B
Janux Therapeutics
Price$24.45
Change+$0.39 (+1.62%)
Volume$302.43K
Capitalization1.42B
IDYA vs JANX Comparison Chart in %
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. JANX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Buy and JANX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (IDYA: $22.10 vs. JANX: $24.45)
Brand notoriety: IDYA and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 43% vs. JANX: 33%
Market capitalization -- IDYA: $1.92B vs. JANX: $1.42B
IDYA [@Biotechnology] is valued at $1.92B. JANX’s [@Biotechnology] market capitalization is $1.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, JANX is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 5 TA indicator(s) are bullish while JANX’s TA Score has 6 bullish TA indicator(s).

  • IDYA’s TA Score: 5 bullish, 3 bearish.
  • JANX’s TA Score: 6 bullish, 1 bearish.
According to our system of comparison, JANX is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а -0.85% price change this week, while JANX (@Biotechnology) price change was +3.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

JANX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.92B) has a higher market cap than JANX($1.42B). IDYA YTD gains are higher at: -14.008 vs. JANX (-54.333). JANX has higher annual earnings (EBITDA): -111.54M vs. IDYA (-356.46M). JANX has more cash in the bank: 1.01B vs. IDYA (693M). JANX has less debt than IDYA: JANX (22.6M) vs IDYA (26M). JANX has higher revenues than IDYA: JANX (9.34M) vs IDYA (7M).
IDYAJANXIDYA / JANX
Capitalization1.92B1.42B135%
EBITDA-356.46M-111.54M320%
Gain YTD-14.008-54.33326%
P/E RatioN/AN/A-
Revenue7M9.34M75%
Total Cash693M1.01B68%
Total Debt26M22.6M115%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAJANX
RSI
ODDS (%)
Bearish Trend 2 days ago
63%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USLCX45.50N/A
N/A
JHancock U.S. Global Leaders Growth C
TAVFX66.19N/A
N/A
Third Avenue Value Instl
SGAPX24.51N/A
N/A
Virtus SGA Global Growth I
HGIIX55.51N/A
N/A
Hartford Core Equity I
DHFIX13.88N/A
N/A
Diamond Hill Large Cap Concentrated I

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+0.82%
IMNM - IDYA
60%
Loosely correlated
+2.43%
CGON - IDYA
60%
Loosely correlated
+0.82%
NRIX - IDYA
58%
Loosely correlated
+2.33%
XENE - IDYA
56%
Loosely correlated
-0.33%
CRNX - IDYA
56%
Loosely correlated
+1.22%
More

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with SKYE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+5.30%
SKYE - JANX
41%
Loosely correlated
+23.26%
CRNX - JANX
39%
Loosely correlated
+1.22%
IDYA - JANX
37%
Loosely correlated
+0.82%
APGE - JANX
36%
Loosely correlated
+7.08%
ORMP - JANX
36%
Loosely correlated
+0.93%
More